Phospholipid-Protein Interactions in the Formation of Prothrombin Activator^[*]

Summary

Since Ac-globulin (factor V) is involved in the formation of prothrombin activator, its ability to complex with phospholipids was studied. Purified bovine Ac-globulin was complexed to asolectin, there being presumably a fixed number of binding sites on the phospholipid micelle for Ac-globulin. In contrast to the requirement for calcium ions in the formation of complexes between asolectin and autoprothrombin C, calcium ions were not required for complex formation between asolectin and Ac-globulin to occur ; in fact, the presence of calcium prevented complex formation occurring, the degree of inhibition being dependent on the calcium concentration. By treating isolated, pre-formed aso- lectin-Ac-globulin complexes with calcium chloride solutions, Ac-globulin could be recovered in a much higher state of purity and essentially free of asolectin.

Complete activators were formed by first preparing the asolectin-calcium- autoprothrombin C complex and then reacting the complex with Ac-globulin. A small amount of this product was very effective as an activator of purified prothrombin without further addition of calcium or any other cofactor. If the autoprothrombin C preparation used to prepare the complex was free of traces of prothrombin, the complete activator was stable for several hours at room temperature. Stable preparations of the complete activator were centrifuged, resulting in the sedimentation of most of the activity. Experimental evidence also indicated that activator activity was highest when autoprothrombin C and Ac-globulin were complexed to the same phospholipid micelle, rather than when the two clotting factors were complexed to separate micelles. These data suggested that the in vivo prothrombin activator may be a sedimentable complex composed of a thromboplastic enzyme, calcium, Ac-globulin and phospholipid.

^* This investigation was supported by the Medical Research and Development Board, Office of the Surgeon General, Department of the Army, under Contract No.DA-49-193-MD-2171, and by the National Heart Institute, National Institutes of Health, under Grant No.HE-03940-06. Some of this material has been presented at the Thirteenth Annual Symposium on Blood, Wayne State University School of Medicine, Detroit, Michigan, January 22nd and 23rd, 1965.

• References

• 1 Macfarlane R. G. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 202: 498 1964;
• 2 Williams W. J. The activity of lung microsomes in coagulation blood. J. biol. Chem. 239: 933 1964;
• 3 Cole E. R, Koppel J. L, Olwin J. H. Interaction of bovine autoprothrombin C with phospholipids and divalent cations. Canad. J. Biochem. 42: 1595 1964;
• 4 Seegers W. H, Cole E. R, Harmison C. R, Marciniak E. Purification and some properties of autoprothrombin C. Canad. J. Biochem. Physiol. 41: 1047 1963;
• 5 MarciniaTc E, Seegers W. H. Autoprothrombin C: A second enzyme from prothrombin. Canad. J. Biochem. Physiol. 40: 597 1962;
• 6 Spaet T. H, Cintron J. Pathways to blood coagulation product I formation. Blood 21: 745 1963;
• 7 Ware A. G, Seegers W. H. Serum Ac-globulin: formation from plasma Ac-globulin; role in blood coagulation; partial purification; properties, and quantitative determination. Amer. J. Physiol. 152: 567 1948;
• 8 Papahadjopoulos D, Hougie C, Hanahan D. J. Purification and properties of bovine factor Y : A change of molecular size during blood coagulation. Biochem 03: 264 1964;
• 9 Breckenridge R. T, Ratnoff O. D. The activation of human proaccelerin by activated Stuart factor. Proc. Cent. Soc. Clin. Res. 37: 14 1964;
• 10 Seaman A. J, Owren P. A. A asolectin adsorbed substrate for proaccelerin assay. J. clin. Invest. 35: 145 1956;
• 11 Speer R. J, Borges J. E. A convenient method for preparation of factor V- deficient plasma. J. Lab. clin. Invest. 60: 833 1962;
• 12 Cole E. R, Koppel J. L, Olwin J. H. Autoprothrombin C from a commercial thrombin product. Nature 202: 301 1964;
• 13 Seegers W. H. The purification of prothrombin. Rec. Chem. Progr. 13: 143 1952;
• 14 Seegers W. H, Smith H. P. Factors which influence the activity of purified thrombin. Amer. J. Physiol. 137: 348 1942;
• 15 Cole E. R, Marciniak E, Seegers W. H. Quantitative determination of autoprothrombin C. Thrombos. Diathes. haemorrh. (Stuttg.) 08: 434 1962;
• 16 Aoki N, Harmison C. R, Seegers W. H. Properties of bovine Ac-globulin concentrates and methods of preparation. Canad. J. Biochem. Physiol. 41: 2409 1963;
• 17 Ware A. G, Seegers W. H. Plasma accelerator globulin: Partial purification, quantitative determination and properties. J. Biol. Chem. 172: 699 1948;
• 18 Folin O, Ciocalteu V. On tyrosine and tryptophane determinations in proteins. J. biol. Chem. 73: 627 1927;
• 19 Seegers W. H, Cole E. R, Aoki N. Function of Ac-globulin and lipid in blood clotting. Canad. J. Biochem. Physiol. 41: 2441 1962;
• 20 Vroman L. Effects of hydrophobic surfaces upon blood coagulation. Thrombos. Diathes. haemorrh. (Stuttg.) 10: 455 1964;
• 21 Blombäck B, Blombäck M. Purification and stabilization of factor V. Nature 198: 886 1963;
• 22 Papahadjopoulos D, Hanahan D. J. Observations on the interaction of phospholipids and certain clotting factors in prothrombin activator formation. Biochem. biophys. Acta (Amst.) 90: 436 1964;
• 23 Straub W, Duckert F. The formation of the extrinsic prothrombin activator. Thrombos. Diathes. haemorrh. (Stuttg.) 05: 402 1961;